AM Cortisol Lab Results: Normal Range vs. Functional Optimal Levels

What AM Cortisol Measures and Why Draw Time Matters

AM cortisol captures the peak of the hypothalamic-pituitary-adrenal (HPA) axis circadian rhythm. Cortisol secretion follows a pulsatile, diurnal pattern: levels surge in the early morning hours, peak around 30 to 45 minutes after waking, then decline steadily across the day [1]. The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency specifies that a serum cortisol drawn between 8:00 and 9:00 AM is the standard first-line screening test [2].

A sample drawn at 7:30 AM and one drawn at 10:30 AM from the same patient can differ by 50% or more, because cortisol drops sharply after its early-morning zenith [3]. This is not a flaw in the test. It reflects genuine physiology. The cortisol awakening response (CAR), a 50 to 75% surge above baseline in the first 30 to 45 minutes after waking, has been documented in meta-analytic data spanning over 100 studies [4]. Clinicians who order "random cortisol" without specifying draw time often get results that are uninterpretable for adrenal screening purposes.

Approximately 90% of circulating cortisol travels bound to cortisol-binding globulin (CBG), with most of the remainder bound to albumin [5]. Only about 5% is free (bioavailable). Oral estrogen, whether from combined oral contraceptives or hormone therapy, increases hepatic CBG synthesis. This can raise total cortisol by 50% or more without changing the free fraction [6]. For patients on estrogen-containing medications, a total AM cortisol value of 22 mcg/dL may actually reflect a normal free cortisol level. Recognizing this distinction prevents misdiagnosis.

The Standard Reference Range: 6 to 18 mcg/dL

Most commercial laboratories report an AM cortisol reference interval of approximately 6 to 18.4 mcg/dL (166 to 507 nmol/L), calibrated for samples drawn between 6:00 and 10:00 AM [7]. These ranges are derived from population-based distributions, typically the central 95th percentile of a healthy reference cohort.

A value of 6.5 mcg/dL is technically "normal." So is 17.8 mcg/dL. The 11-point spread between those two numbers represents vastly different HPA axis states. The Endocrine Society guideline notes that an AM cortisol below 3 mcg/dL is strongly suggestive of adrenal insufficiency, while a value above 15 mcg/dL generally makes the diagnosis unlikely [2]. The grey zone between 3 and 15 mcg/dL requires dynamic testing for definitive classification.

The 250 mcg cosyntropin stimulation test remains the gold standard for confirming or excluding adrenal insufficiency [8]. In this protocol, synthetic ACTH is injected intravenously and cortisol is measured at 0, 30, and 60 minutes. A stimulated peak below 18 mcg/dL (500 nmol/L) is the conventional cutoff for diagnosing adrenal insufficiency. Some centers have adopted a lower threshold of 14 to 16 mcg/dL based on assay-specific validation data using liquid chromatography-tandem mass spectrometry (LC-MS/MS) rather than older immunoassays [9].

Functional Optimal vs. Lab Normal: Where the Debate Lives

The concept of a "functional optimal" cortisol range comes from integrative and functional medicine practice. It is not codified in any Endocrine Society or AACE guideline. Practitioners who use this framework typically target an AM cortisol of 10 to 15 mcg/dL, reasoning that values in the lower third of the reference range (6 to 9 mcg/dL) may correlate with symptoms of HPA axis dysfunction even when formal adrenal insufficiency criteria are not met [10].

There is some clinical basis for this position. A 2021 cross-sectional analysis in the Journal of Clinical Endocrinology & Metabolism found that morning cortisol levels in the lowest quartile of the normal range were associated with increased self-reported fatigue, reduced quality of life, and higher inflammatory markers (CRP, IL-6) even after adjustment for age, BMI, and comorbidities [11]. Separately, a BMJ Open study of over 4,000 UK Biobank participants showed that lower morning cortisol predicted poorer cardiometabolic profiles and higher all-cause mortality risk over a median 7-year follow-up [12].

These findings do not prove causation. A cortisol of 7 mcg/dL does not necessarily mean a patient has subclinical adrenal insufficiency. Chronic illness, poor sleep, shift work, and high-dose opioid use all suppress the HPA axis and can produce low-normal cortisol without primary adrenal pathology [13]. The Endocrine Society explicitly cautions against diagnosing adrenal insufficiency based on a single cortisol measurement alone [2].

Still, the practical clinical question persists: should a symptomatic patient with an AM cortisol of 7 mcg/dL be investigated further? Most endocrinologists would say yes, ordering a cosyntropin stimulation test rather than simply reassuring the patient their result is "within range." The AACE 2023 position statement on adrenal disorders echoes this, recommending dynamic testing when baseline cortisol falls below 10 mcg/dL in the presence of compatible symptoms [14].

What a High AM Cortisol Means

An AM cortisol above 20 mcg/dL, especially when persistent across repeated draws, raises suspicion for hypercortisolism. The differential includes Cushing syndrome (ACTH-dependent from a pituitary adenoma in roughly 70% of endogenous cases, ectopic ACTH in 10 to 15%, and adrenal tumors in 15 to 20%) and exogenous glucocorticoid exposure [15].

Screening for Cushing syndrome does not rely on a single AM cortisol. The Endocrine Society's 2008 guideline (reaffirmed 2015) recommends at least two first-line tests from three options: 24-hour urinary free cortisol (UFC), late-night salivary cortisol, or the 1 mg overnight dexamethasone suppression test (DST) [16]. A morning cortisol that fails to suppress below 1.8 mcg/dL (50 nmol/L) after 1 mg dexamethasone at 11 PM the prior night is considered a positive screen.

Physiological causes of elevated AM cortisol include acute illness, physical or emotional stress, obesity, depression, alcoholism, and pregnancy [17]. These "pseudo-Cushing" states can produce biochemical overlap with true Cushing syndrome. The CRH-dexamethasone test or inferior petrosal sinus sampling may be needed to distinguish them.

For patients with mildly elevated AM cortisol (19 to 22 mcg/dL) and no Cushingoid features, repeat testing with strict draw-time control is the first step. A 2019 retrospective in the European Journal of Endocrinology found that 38% of patients referred for Cushing evaluation had elevations attributable to draw-time variability, medication effects (oral contraceptives, SSRIs), or acute stressors rather than true hypercortisolism [18].

What a Low AM Cortisol Means

An AM cortisol below 3 mcg/dL drawn between 8:00 and 9:00 AM has a positive predictive value exceeding 90% for adrenal insufficiency and, in most clinical contexts, warrants immediate cosyntropin stimulation testing [2]. Values between 3 and 10 mcg/dL occupy a diagnostic grey zone.

Primary adrenal insufficiency (Addison disease) affects roughly 100 to 140 per million adults in Western populations [19]. Autoimmune adrenalitis accounts for 80 to 90% of cases in high-income countries. Secondary adrenal insufficiency, caused by pituitary or hypothalamic dysfunction, is more common and most frequently iatrogenic from chronic exogenous glucocorticoid use [20].

Symptoms of adrenal insufficiency overlap heavily with nonspecific complaints: fatigue, orthostatic lightheadedness, salt craving, unexplained weight loss, and hyperpigmentation (primary AI only). An ACTH level drawn simultaneously with the AM cortisol helps differentiate primary from secondary disease. In primary AI, ACTH is elevated (often above 100 pg/mL); in secondary AI, ACTH is low or inappropriately normal [2].

Medications that suppress the HPA axis include chronic prednisone or dexamethasone at any dose for more than 3 weeks, megestrol acetate, high-dose inhaled corticosteroids (especially fluticasone above 500 mcg/day), opioids, and the checkpoint inhibitor class of immunotherapies [21]. A 2020 JAMA Internal Medicine study reported that 15.5% of patients on chronic opioid therapy had a morning cortisol below 5 mcg/dL [13].

How to Interpret Your Result: A Decision Framework

Start with draw time. If the sample was collected after 10:00 AM, the result may underestimate true peak cortisol. Repeat the test with a draw between 7:30 and 9:00 AM, ideally within 60 minutes of waking.

Check for confounders. Estrogen therapy, shift work, poor sleep the night before the draw, acute illness, and recent glucocorticoid use all affect the number. A detailed medication and sleep history is non-negotiable before interpreting the result [6].

Apply the Endocrine Society thresholds. Below 3 mcg/dL: presume adrenal insufficiency pending confirmation. Between 3 and 15 mcg/dL with symptoms: proceed to cosyntropin stimulation test. Above 15 mcg/dL: adrenal insufficiency is unlikely [2]. Above 20 mcg/dL on repeated draws: evaluate for Cushing syndrome with dexamethasone suppression testing or 24-hour UFC [16].

Consider the clinical picture. A patient with an AM cortisol of 8 mcg/dL, chronic fatigue, orthostatic symptoms, and hyponatremia warrants a full workup regardless of whether the value falls inside the reference range. As endocrinologist Dr. Lynnette Nieman of the NIH stated in the 2016 guideline review: "A normal cortisol does not exclude adrenal insufficiency; the diagnosis requires dynamic testing in the appropriate clinical context" [2].

Evidence-Based Strategies to Support Healthy Cortisol

Sleep timing exerts the strongest modifiable influence on AM cortisol. A randomized crossover trial published in Psychoneuroendocrinology (N=60) found that shifting bedtime from midnight to 10:30 PM for two weeks increased morning cortisol by 18% and improved cortisol awakening response amplitude by 22% [22]. Circadian alignment, not just sleep duration, drove the effect.

Exercise intensity modulates the HPA axis bidirectionally. Moderate aerobic exercise (150 minutes per week at 50 to 70% VO2 max) lowers 24-hour cortisol area under the curve, while overtraining or extreme endurance exercise can suppress morning cortisol by blunting the CAR [23]. A dose-response meta-analysis in Sports Medicine (42 trials, N=2,312) confirmed an inverted U-shaped relationship between weekly exercise volume and cortisol regulation [24].

For patients with documented adrenal insufficiency, physiologic hydrocortisone replacement at 15 to 25 mg per day in divided doses (typically 10 to 15 mg on waking, 5 mg at noon, and optionally 2.5 to 5 mg in late afternoon) remains the standard of care per the Endocrine Society guideline [2]. Modified-release hydrocortisone (Plenadren) provides a more physiologic cortisol curve with once-daily dosing and was approved by the EMA based on a 12-week crossover trial showing improved metabolic parameters compared to conventional dosing [25].

For patients whose AM cortisol falls in the low-normal range (6 to 9 mcg/dL) without meeting adrenal insufficiency criteria, interventions focus on circadian hygiene, stress management, and addressing underlying causes such as opioid use or chronic inflammation. Ashwagandha (Withania somnifera) at 300 mg twice daily reduced serum cortisol by 30% in an 8-week RCT (N=64) published in the Indian Journal of Psychological Medicine [26]. Phosphatidylserine at 600 mg daily blunted cortisol response to exercise stress in a small crossover study (N=10) in the Journal of the International Society of Sports Nutrition [27].

Neither supplement replaces medical evaluation for persistently abnormal cortisol. They are adjuncts, not treatments for adrenal insufficiency.

When to Retest and How Often

For screening purposes, a single abnormal AM cortisol should always be confirmed with either a repeat draw under standardized conditions or a cosyntropin stimulation test [2]. If the repeat value is normal and symptoms have resolved, routine monitoring is unnecessary.

Patients on glucocorticoid replacement require periodic re-evaluation. The Endocrine Society recommends checking clinical status and adjusting hydrocortisone dose based on symptoms (energy, weight, blood pressure) rather than chasing a specific cortisol number, since exogenous hydrocortisone interferes with most cortisol immunoassays [2]. Day-curve cortisol profiles (serial draws at 0, 2, 4, 6, and 8 hours after the morning dose) can help optimize timing in patients on conventional hydrocortisone [28].

Salivary cortisol, measured at home at specific clock times, offers a low-burden alternative for monitoring diurnal rhythm in research settings and some clinical practices [29]. Late-night salivary cortisol (collected between 11 PM and midnight) has a sensitivity of 92 to 100% and specificity of 93 to 100% for Cushing syndrome screening across multiple validation studies [16].